Navigation Links
Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights
Date:3/3/2011

ck warrant liability2,0291,2792,016(151)Total other income, net2,0541,3232,155459Net loss (1)

$

(2,426)$

(4,257)$

(16,349)$

(27,278)Net loss per share, basic and diluted (1)

$

(0.04)$

(0.11)$

(0.38)$

(0.81)Share used in calculating net loss per share,basic and diluted54,25437,32643,57033,775(1) Includes non-cash share-based expenses of $322 and $384 for the three months ended December 31, 2010 and 2009, respectively. Research and development expense and general and administrative expense includes $82 and $240, respectively, of non-cash share-based expenses for the three months ended December 31, 2010. Includes non-cash share-based expenses of $1,779 and $2,715 for the twelve months ended December 31, 2010 and 2009, respectively. Research and development expense and general and administrative expense includes $725 and $1,054, respectively, of non-cash share-based expenses for the twelve months ended December 31, 2010.Anadys Pharmaceuticals, Inc.Condensed Consolidated Balance Sheets(In thousands)December 31,December 31,20102009(Unaudited)(Audited)AssetsCash, cash equivalents and securities available-for-sale$

37,984$

20,490Other current assets1,319559Noncurrent assets234686Total assets$

39,537$

21,735Liabilities and Stockholders' EquityCurrent liabilities$

2,970$

3,383Common stock warrant liability1,8813,897Other long-term liabilities1326Stockholders' equity34,67314,429Total liabilities and stockholders' equity$

39,537$

21,735About Anadys Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  Anadys is conducting a Phase IIb study of ANA598, the Com
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Anadys Pharmaceuticals Augments Management Team and Board of Directors
2. Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
3. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
4. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
5. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
6. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
7. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
8. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
9. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
10. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
11. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... SoundConnect’s 2015 next generation ... communication technology, provide continued education and inform users ... demonstrates online communication features and benefits; empowering users ... innovative and powerful tools. , According to SoundConnect’s ...
(Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 Nashville ... was elected treasurer for the American Society for Reproductive Medicine ... research in reproductive medicine. In his new role as ... board and will have a voice in furthering the mission ...
(Date:12/24/2014)... Pipette.com announces their Holiday in the ... #HolidayInTheLab pictures for a chance to win pipette-themed gifts for ... think of a holiday gift for their beloved lab mates, ... holiday presents. The #HolidayInTheLab Contest encourages Pipette.com Twitter followers ...
Breaking Biology Technology:SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2
... University have created a new kind of polymer ... properties, could be used in everything from airplanes ... that incorporates functionalized, exfoliated graphene sheets, even conducts ... to eventually create thermally stable, optically transparent conducting ...
... driven by,a broad range of improvements in hardware and ... applications in the clinic, according,to an article in the ... ( http://www.genengnews.com ). Mass spec is also playing a ... on screening patients through,the identification of biomarkers and developing ...
... Demonstrated for, Eradicating Barrett,s Esophagus and Reducing Risk ... Booth #2349 -- Digestive Disease Week,-- BARRX ... and manufacture,of medical devices for digestive diseases, today ... Randomized, Multicenter, Sham-Controlled,Trial of Radiofrequency Ablation (RFA) for ...
Cached Biology Technology:By adding graphene, researchers create superior polymer 2Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery 2Presentation of Landmark Clinical Trial Evaluating Endoscopic Treatment for Pre-cancerous Condition of Esophagus 2Presentation of Landmark Clinical Trial Evaluating Endoscopic Treatment for Pre-cancerous Condition of Esophagus 3
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., the ... study that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four hundred years ... as a meeting place for peoples from different continents. This ...
(Date:12/17/2014)... 2014  HITLAB SM announced today its completion of ... adherence to current U.S. Food and Drug Administration (FDA) ... device and smart phone application trials utilizing the highest ... "HITLAB is determined to improve global healthcare access, quality, ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has ... Market 2015-2019" report to their offering. ... is a technology used for the identification of individuals. ... a person such as nose, jaw edges, mouth, and ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... at Oregon State University have developed a new technology ... revolutionize the food industry, improving the actual protection to ... of products that are suspected of bacterial contamination but ... possible by fundamental research on the color changes in ...
... Researchers at Sentara Cardiovascular Research Institute begin a new ... stents to open airways of patients with advanced emphysema ... EASE (Exhale Airway Stents for Emphysema) Trial focuses on ... new pathways to release trapped air from within diseased ...
... occur as a by-product of aerobic metabolism and ... lipids. Organisms possess a variety of anti-oxidant ... the oxidative stress model of aging and senescence ... to lifetime accrual of ROS-induced damage and progressively ...
Cached Biology News:Advance offers revolution in food safety testing 2Advance offers revolution in food safety testing 3Sentara begins international trial -- open at only 24 US locations 2Researchers discover that growing up too fast may mean dying young in honey bees 2Researchers discover that growing up too fast may mean dying young in honey bees 3
... anti-phospho-FAK (Ser843) ... acid region encompassing the human, mouse, ... Accession Number: NM_153831 ... Routinely evaluated by immunoblot. ...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Phospho-YAP (Ser127) Antibody Ship: Hot Store: -20 C...
Biology Products: